Sponsor pipeline

CND Life Sciences clinical trial pipeline

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Not charted: 6 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Not specified
NCT07428447	Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of…	Essential Tremor, Movement Disorders	Recruiting	2026-10-13
NCT07204652	Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis	PARKINSON DISEASE (Disorder)	Recruiting	2026-02-11
NCT07217054	Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's…	PARKINSON DISEASE (Disorder)	Recruiting	2026-02-11
NCT06621602	Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective…	REM Behavior Disorder	Active, Not Recruiting	2026-02-11
NCT05479552	A Diagnostic Test for Dementia With Lewy Bodies	MCI-AD, Early Stage Alzheimer's Disease	Active, Not Recruiting	2025-01-15
NCT05757206	The Syn-Sleep Study	REM Sleep Behavior Disorder (iRBD)	Active, Not Recruiting	2025-01-15

Get alerts when CND Life Sciences's trials change

Status changes, date slips, and new filings: detected daily, delivered to your inbox.